The GOALPOST Trial builds on the findings of CHAP and Sinkey’s preliminary clinical trial, called the ACHIEVE Trial, which is ...
Biomed Industries, Inc. Unveils a New Neurogenesis Hypothesis with Clinical Data of NA-831 for Alzheimer's and NA-901 for Major Depressive Disorder Treatment Neurogenesis Hypothesis offers a promising ...
More than two years after the FDA held a public workshop on measuring overall survival (OS) in clinical cancer trials, the agency has released a draft guidance on the topic, recommending that OS be ...
The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...
Google's advanced AI, C2S-Scale 27B, developed with Yale, has generated and validated a novel hypothesis on cancer cell behaviour. This AI understands cellular language, predicting that the drug ...